Is Semaglutide the Same as Ozempic? Brand, Generic, Compounded
Ozempic is a brand of semaglutide, so the medicine inside is the same; Wegovy and Rybelsus are the other semaglutide brands. Ozempic is approved for type 2 diabetes and heart risk, along with kidney disease in type 2 diabetes.
- Ingredient
- semaglutide
- Manufacturer
- Novo Nordisk
- Other semaglutide brands
- Wegovy and Rybelsus
- Lowest semaglutide self-pay
- $149 per month, Wegovy
Ozempic and Wegovy: a quick look
Side-by-side look at Ozempic and Semaglutide
Every row has the same ingredient. A brand's label is what decides the uses that are approved, the forms it comes in, and the price.
| Medicine | Ingredient | How it is taken | Approved for | Trial weight loss | Most common side effect | Self-pay from | List price |
|---|---|---|---|---|---|---|---|
| semaglutide | Weekly injection | Type 2 diabetes and heart risk, along with kidney disease in type 2 diabetes | Not listed | Nausea 20.3% vs 6.1% on placebo | $199 per month | $1,027.51 per pen | |
| semaglutide | Weekly injection or daily tablet | Weight loss, heart risk and MASH liver disease | 14.9% | Nausea 44% vs 16% on placebo | $149 per month | $1,349.02 per month | |
| semaglutide | Daily tablet | Type 2 diabetes and heart risk | Not listed | Nausea 20% vs 6% on placebo | Not listed | $1,027.51 per 30 tablets |
Price and coverage: a comparison
| Medicine | How you pay | Price |
|---|---|---|
| List price before insurance | $1,027.51 per pen | |
| Ozempic Savings Offer (insured) | starting at $25 per month, for terms of up to 3 months | |
| Self-pay: Ozempic pill (from 1.5 mg) | $149 per month | |
| List price before insurance | $1,349.02 per month | |
| Wegovy Savings Offer (insured) | from $25 per month | |
| Self-pay: Wegovy pill 1.5 mg | $149 per month | |
| Medicare GLP-1 Bridge (Wegovy, eligible Part D) | $50 per month | |
| List price before insurance | $1,027.51 per 30 tablets | |
| RYBELSUS Savings Offer (insured) | for prices starting at $25, select a 1-, 2- or 3-month fill |
Generic and compounded Semaglutide options
The injection shortage ended on February 21, 2025. Discontinuation is underway for older Rybelsus tablets.